In the ever-evolving landscape of weight management, one prescription medication has emerged as a promising solution – Qsymia. But what makes Qsymia stand out, and who can benefit from this innovative treatment? The answer to this question may surprise you1.
Qsymia is a prescription weight loss medication designed to help adults and adolescents aged 12 and older manage their weight effectively1. This unique formulation combines two active ingredients, phentermine and topiramate, to suppress appetite and increase metabolic rate, making it a powerful tool in the fight against obesity and overweight1.
But what sets Qsymia apart? The key lies in its targeted approach to weight management. Qsymia is approved for chronic weight management in adults with a body mass index (BMI) of 30 kg/m2 or greater (obese) or 27 kg/m2 or greater (overweight) with at least one weight-related medical condition, such as high blood pressure, type 2 diabetes, or high cholesterol1. Additionally, Qsymia is also approved for use in pediatric patients aged 12 and older with a BMI in the 95th percentile or greater standardized for age and sex1.
Key Takeaways
- Qsymia is a prescription weight loss medication that combines phentermine and topiramate to suppress appetite and increase metabolism.
- Qsymia is approved for chronic weight management in adults with a BMI of 30 kg/m2 or greater (obese) or 27 kg/m2 or greater (overweight) with at least one weight-related medical condition.
- Qsymia is also approved for use in pediatric patients aged 12 and older with a BMI in the 95th percentile or greater for their age and sex.
- Qsymia has been shown to be an effective weight loss solution for those struggling with obesity and overweight conditions.
- Healthcare providers should closely monitor patients taking Qsymia for potential side effects and adverse reactions.
Qsymia: A Prescription Weight Loss Solution
Qsymia is a prescription weight loss medication that must be used in combination with a reduced-calorie diet and increased physical activity for chronic weight management2. It is not known if Qsymia changes the risk of heart problems, stroke, or death due to these conditions2. Qsymia is also not known to be safe and effective when taken with other prescription, over-the-counter, or herbal weight loss products.
Clinical trials have shown that Qsymia can be an effective weight loss solution. In studies of adults, those who took the recommended dose of Qsymia lost an average of 15 lbs after approximately 3 months, compared to 5 lbs lost by individuals managing weight through diet and exercise (placebo group)3. Furthermore, individuals who took Qsymia for about 1 year lost an average of 24 lbs, in contrast to 6 lbs lost by those in the placebo group3.
Qsymia has also been approved by the FDA for use in children aged 12 years and above who are obese3. However, it’s important to note that a child’s BMI or weight status is evaluated differently from adult BMI categories, based on growth charts for children3.
Due to the potential risks associated with Qsymia, the FDA requires a Risk Evaluation and Mitigation Strategy (REMS) program for this medication3. Additionally, breastfeeding while taking Qsymia is not recommended, as the medication can pass into breast milk and pose risks to the baby3. Individuals taking Qsymia are also advised to consult with their provider about consuming alcohol, as it can worsen dizziness and cognitive impairment caused by the medication3.
Overall, Qsymia can be a useful prescription weight loss solution when combined with a reduced-calorie diet and increased physical activity. However, it’s important to follow the instructions and guidance of healthcare providers to ensure the safe and effective use of this medication23.
How Does Qsymia Work for Weight Management?
Appetite Suppression and Increased Metabolic Rate
Qsymia, a prescription weight loss medication, utilizes a unique combination of two active ingredients, phentermine and topiramate, to facilitate weight management4. Phentermine acts as an appetite suppressant, reducing feelings of hunger and cravings throughout the day5. Topiramate, on the other hand, helps increase the body’s metabolic rate, leading to greater calorie expenditure. By targeting both appetite and metabolism, Qsymia aims to support sustainable weight loss and long-term weight management.
In clinical trials, patients using the recommended dosage of Qsymia 15 / 92 mg, along with diet and exercise, lost an average of 14.5 kg (32 lb) and about 5 inches off their waist, while those using a placebo lost only 2.7 kg (6 lb) and 1.7 inches5. This dual-action approach of Qsymia has proven effective in helping individuals manage their weight and achieve their health and wellness goals.
| Metric | Qsymia 15 / 92 mg | Placebo |
|---|---|---|
| Weight Loss | 14.5 kg (32 lb) | 2.7 kg (6 lb) |
| Waist Circumference Reduction | 5 inches | 1.7 inches |
It’s important to note that Qsymia is considered a controlled substance (C-IV) due to its phentermine component, which can make it susceptible to abuse or lead to drug dependence5. As such, it is crucial for individuals to follow the prescribed dosage regimen and consult with their healthcare provider to ensure safe and effective use of this medication.
By addressing both appetite and metabolism, Qsymia aims to provide a comprehensive approach to weight management, helping individuals achieve their goals while maintaining their overall health and well-being45.
Who Can Take Qsymia?
Criteria for Adults and Adolescents
Qsymia is a prescription weight loss medication approved for use in certain individuals. For adults, Qsymia is indicated for those with a body mass index (BMI) of 30 kg/m2 or greater (obese) or 27 kg/m2 or greater (overweight) with at least one weight-related medical condition, such as high blood pressure, type 2 diabetes, or high cholesterol6.
Qsymia is also approved for use in pediatric patients aged 12 years and older with a BMI in the 95th percentile or greater, standardized for age and sex6.
| Qsymia Eligibility Criteria | Adults | Adolescents (12 years and older) |
|---|---|---|
| Body Mass Index (BMI) | 30 kg/m2 or greater (obese) or 27 kg/m2 or greater (overweight) | 95th percentile or greater, standardized for age and sex |
| Additional Requirement | At least one weight-related medical condition (e.g., high blood pressure, type 2 diabetes, high cholesterol) | None |
It’s important to note that Qsymia is not recommended for use during pregnancy due to the risk of birth defects7. Additionally, Qsymia may result in a slower increase in height in children aged 12 years and older7.
Patients considering Qsymia should discuss the potential benefits and risks with their healthcare provider to determine if it is the right weight management solution for their individual needs8.
Potential Benefits of Qsymia
Qsymia, a prescription medication, has been shown to be an effective solution for individuals struggling with weight management. Clinical studies have demonstrated that Qsymia can lead to significant weight loss when combined with a reduced-calorie diet and increased physical activity9. Furthermore, Qsymia has been associated with improvements in weight-related medical conditions, such as high blood pressure, type 2 diabetes, and high cholesterol10.
In a large clinical trial, patients receiving Qsymia experienced weight losses averaging 7.8% in the mid-dose group and 9.8% in the full-dose group, compared to 1.2% in the placebo group after 56 weeks10. Patients taking the maximum dose of Qsymia (15/92 mg) lost an average of 11% of their body weight after one year of treatment11.
Qsymia has also been shown to provide additional health benefits beyond weight loss. Patients receiving Qsymia experienced greater improvements in waist circumference, blood pressure, blood glucose, and cholesterol levels compared to those in the placebo group10. Over two years, Qsymia can lower systolic and diastolic blood pressure by 3 to 5 mm Hg and A1C levels in patients with diabetes by 0.2% to 0.4%11.
By facilitating long-term weight management and addressing various health parameters, Qsymia aims to provide comprehensive benefits for adults and adolescents struggling with obesity or overweight910.
Qsymia Dosage and Administration
Qsymia, a weight loss medication, is typically started at a lower dose and gradually increased through a process called titration12. The recommended starting dosage is 3.75 mg/23 mg (phentermine/topiramate) taken orally once daily for 14 days before increasing to 7.5 mg/46 mg12.
Titration and Maintenance Regimens
After 12 weeks of treatment with the 7.5 mg/46 mg dose, healthcare providers will monitor the patient’s progress. If an adult patient hasn’t lost at least 3% of their baseline body weight or a pediatric patient aged 12 hasn’t experienced a reduction of at least 3% of their baseline BMI, the dosage should be increased to 11.25 mg/69 mg for another 14 days and then to 15 mg/92 mg taken orally once daily12.
If, after 12 weeks of treatment with the 15 mg/92 mg dose, an adult patient hasn’t lost at least 5% of their baseline body weight or a pediatric patient aged 12 hasn’t experienced a reduction of at least 5% of their baseline BMI, Qsymia should be discontinued12. Discontinuation of the 15 mg/92 mg dose should be gradual, with the medication taken once daily every other day for at least 1 week prior to stopping treatment altogether12.
| Dosage | Indication | Discounts |
|---|---|---|
| 3.75 mg/23 mg | Initial 14 days | $65 off for 14-15 days (commercial insurance) $70 off for 14-15 days (cash pay) |
| 7.5 mg/46 mg | Maintenance | $65 off for 28-30 days (commercial insurance) $75 off for 28-30 days (cash pay) |
| 15 mg/92 mg | Maintenance | $65 off for 28-30 days (commercial insurance) $75 off for 28-30 days (cash pay) |
Patients with severe or moderate renal impairment should be prescribed a maximum dosage of 7.5 mg/46 mg once daily, while those with mild renal impairment can take the same dosage as patients with normal renal function12. Qsymia should be avoided in patients with end-stage renal disease on dialysis12.
For patients with severe hepatic impairment, Qsymia should be avoided, and for those with moderate hepatic impairment, the maximum recommended dosage is 7.5 mg/46 mg once daily12. The dosage for patients with mild hepatic impairment is the same as for those with normal hepatic function12.
“It’s important to work closely with your healthcare provider to determine the appropriate Qsymia dosage and monitor your progress throughout the treatment process.”
Proper dosage and administration of Qsymia, as well as ongoing communication with a healthcare professional, are crucial for achieving successful weight loss outcomes121314.
Important Safety Information for Qsymia
When it comes to weight loss medications, safety is of paramount importance. Qsymia, a prescription weight loss solution, carries some serious safety considerations that patients should be aware of before starting treatment151617.
One of the most concerning potential side effects of Qsymia is the risk of suicidal thoughts or actions. Patients taking Qsymia may experience mood changes, confusion, and even suicidal ideation16. Regular check-ups and monitoring for these symptoms are essential during Qsymia treatment17.
Qsymia can also cause eye problems, including sudden vision loss and secondary angle closure glaucoma16. Patients should be on the lookout for any changes in their vision and report them to their healthcare provider immediately.
Another serious safety concern with Qsymia is the risk of birth defects, including cleft lip and cleft palate, if taken during pregnancy16. Qsymia is contraindicated in pregnant women, and monthly negative pregnancy tests are required during treatment17.
| Potential Serious Side Effects of Qsymia |
|---|
| Suicidal thoughts or actions |
| Eye problems (sudden vision loss, glaucoma) |
| Birth defects (if taken during pregnancy) |
| Increased heart rate |
| Metabolic acidosis |
| Kidney stones |
| Severe rash |
Qsymia can also cause other serious side effects, such as increased heart rate, metabolic acidosis, kidney stones, and severe rash16. Patients with certain medical conditions, such as glaucoma or hyperthyroidism, or those taking specific medications, such as monoamine oxidase inhibitors (MAOIs), should not use Qsymia17.
It’s crucial for patients to discuss all their medical conditions and current medications with their healthcare provider before starting Qsymia treatment17. By understanding the potential risks and taking the necessary precautions, patients can make an informed decision about whether Qsymia is the right weight loss medication for them.
Qsymia and Pregnancy: Risks and Precautions
Qsymia, a prescription weight loss medication, is not recommended for use during pregnancy as it can increase the risk of birth defects, particularly cleft lip and cleft palate18. Data from pregnancy registries and epidemiologic studies suggest an increased risk of major congenital malformations associated with Qsymia use18. To minimize the risk, patients who can become pregnant should undergo a pregnancy test before starting Qsymia and continue to have monthly pregnancy tests while taking the medication19.
Effective birth control (contraception) should be used consistently during Qsymia treatment19. Patients who become pregnant while taking Qsymia should stop the medication immediately and notify their healthcare provider19. While animal studies on phentermine and topiramate, the active ingredients in Qsymia, did not reveal fetal malformations at specific doses18, topiramate has been associated with an increased risk of major congenital malformations, such as oral clefts, in infants exposed during the first trimester of pregnancy18.
Additionally, exposure to topiramate in utero has been linked to a higher risk of small-for-gestational-age newborns18. Phentermine, on the other hand, is not teratogenic but may result in lower body weight and reduced survival of offspring18. Maternal obesity also increases the risk of congenital malformations, underscoring the importance of weight management before and during pregnancy18.
Breastfeeding is not recommended during Qsymia use, as both phentermine and topiramate are excreted into human milk18. Breastfed infants may experience adverse reactions, such as changes in sleep, irritability, hypertension, vomiting, tremor, and weight loss due to maternal use of phentermine18. Topiramate concentrations in maternal colostrum and infant serum also indicate a transfer of the drug to the infant18.
In summary, Qsymia is contraindicated for use during pregnancy due to the increased risk of birth defects. Patients who can become pregnant should use effective contraception and undergo regular pregnancy testing while on Qsymia. If pregnancy is suspected or confirmed, the medication should be discontinued immediately, and the healthcare provider should be notified. Breastfeeding is also not recommended during Qsymia treatment1819.
Monitoring During Qsymia Treatment
Patients taking the weight loss medication Qsymia will need to undergo regular check-ups and laboratory tests to monitor for potential side effects and ensure the medication is working effectively20. Healthcare providers will closely monitor the patient’s heart rate, watch for signs of metabolic acidosis, and perform other necessary tests to assess the patient’s overall health and safety during Qsymia treatment20.
Regular Check-ups and Lab Tests
It is crucial for patients on Qsymia to attend scheduled check-ups with their healthcare provider. During these appointments, the provider will measure the patient’s heart rate, monitor for any concerning changes, and order laboratory tests as needed20. These tests may include blood work to check for signs of metabolic acidosis or other potential side effects20.
- Regular monitoring of heart rate and blood pressure
- Periodic laboratory tests to assess metabolic health
- Evaluation of any potential side effects or complications
By staying vigilant with Qsymia monitoring, healthcare providers can ensure the safety and efficacy of this weight loss medication for their patients20. Regular check-ups and lab tests are essential components of a successful Qsymia treatment plan20.
“Consistent monitoring and follow-up care are key to managing Qsymia treatment and minimizing potential risks.”
| Monitoring Aspect | Frequency | Purpose |
|---|---|---|
| Heart rate | At each visit | Detect changes that may require dose adjustment or discontinuation |
| Metabolic acidosis | Periodically | Identify any buildup of acid in the blood |
| Other laboratory tests | As needed | Evaluate overall health and safety during Qsymia treatment |
Possible Side Effects of Qsymia
When taking Qsymia, a prescription weight loss medication, patients may experience a range of potential side effects21. Some of the most common side effects reported include numbness, tingling or burning sensation in the arms, feet or face, dizziness, changes in taste or loss of taste, trouble sleeping, constipation, and dry mouth21.
More serious side effects, such as suicidal thoughts or actions, eye problems, metabolic acidosis, and kidney stones, can also occur21. Patients should be vigilant and report any side effects to their healthcare provider, especially if they are persistent or worrying21.
In clinical trials, the occurrence rates of common adverse reactions with Qsymia at a rate of greater than or equal to 5% and at least 1.5 times placebo include paraesthesia, dizziness, dysgeusia, insomnia, constipation, and dry mouth22. The incidence of these side effects varied depending on the dosage level of Qsymia22.
| Adverse Reaction | Qsymia Dosage Levels | Placebo |
|---|---|---|
| Paraesthesia | 4.2%, 13.7%, 19.9% | 1.9% |
| Dysgeusia | 1.3%, 7.4%, 9.4% | 1.1% |
| Mood and Sleep Disorders | 15.8%, 14.5%, 20.6% | 10.3% |
| Sleep Disorders | 6.7%, 8.1%, 11.1% | 5.8% |
| Cognitive-related Reactions | 2.1%, 5.0%, 7.6% | 1.5% |
| Decreased Serum Bicarbonate | 8.8%, 6.4%, 12.8% | 2.1% |
| Decreased Serum Potassium | 0.4%, 3.6%, 4.9% | 1.1% |
| Increased Serum Creatinine | 2.1%, 7.2%, 8.4% | 2.0% |
Patients taking Qsymia should report any side effects to their healthcare provider, as some may require dose adjustments or additional monitoring21. It is crucial to maintain open communication with the medical team to ensure the safe and effective use of this weight loss medication21.
“The safety profile of Qsymia is an important consideration for patients and healthcare providers when deciding on a weight management approach. Monitoring for potential side effects and addressing them promptly is crucial for optimizing treatment outcomes.”
Qsymia: Cost and Affordability Options
Insurance Coverage and Savings Programs
The average retail pharmacy price for a 30-day supply of Qsymia is $75 for patients covered by commercial insurance, after a $70 copay23. However, for patients paying cash or if Qsymia is not covered by their insurance, the average price can be as high as $13423. Fortunately, there are several cost-saving options available to make Qsymia more affordable.
Patients with commercial insurance coverage may be eligible for savings programs that can provide up to $65 or $75 off the cost of Qsymia, depending on the dose and quantity23. Additionally, home delivery pharmacy options can offer further cost savings, with an average price of $98 for a 30-day prescription, including shipping23.
While the manufacturer’s published list price for Qsymia is $19724, patients can save up to $10 per fill off the retail price and even up to 80% without using insurance by utilizing an Optum Perks coupon24. Patients may also be able to reduce the cost of Qsymia by obtaining a 90-day supply or using a mail-order pharmacy24.
| Qsymia Cost and Savings | Details |
|---|---|
| Average Retail Price (30-day supply) | $75 with insurance, $134 without insurance23 |
| Insurance Savings Programs | Up to $65 or $75 off, depending on dose and quantity23 |
| Home Delivery Pharmacy Price | $98 for 30-day supply, including shipping23 |
| Manufacturer’s List Price | $19724 |
| Savings with Optum Perks Coupon | Up to 80% off retail price24 |
| 90-day Supply and Mail-order Pharmacy | Can reduce overall cost24 |
By taking advantage of these cost-saving options, patients can ensure that Qsymia remains an affordable and accessible weight management solution2324.
Lifestyle Changes with Qsymia
Qsymia is designed to be used in combination with a reduced-calorie diet and increased physical activity for effective chronic weight management25. Patients taking Qsymia are encouraged to make lifestyle changes, such as adopting a balanced, calorie-controlled diet and engaging in regular exercise, to support their weight loss goals and overall health. Healthcare providers can provide guidance on appropriate dietary and exercise recommendations to complement Qsymia treatment.
A calorie-controlled diet is crucial when using Qsymia, as the medication helps suppress appetite and increase metabolism25. Patients are advised to follow a balanced, nutrient-rich diet with a focus on whole foods, fruits, vegetables, lean proteins, and complex carbohydrates. Portion control and mindful eating habits can also contribute to successful weight loss while taking Qsymia.
Regular physical activity is another essential component of a comprehensive weight management plan with Qsymia25. Healthcare providers may recommend a combination of aerobic exercises, such as brisk walking, jogging, or swimming, along with strength-training activities to build muscle and boost metabolism. Patients are encouraged to gradually increase their physical activity levels and find enjoyable activities that they can incorporate into their daily routines.
| Lifestyle Changes with Qsymia | Benefits |
|---|---|
| Calorie-controlled, balanced diet | Supports weight loss efforts by creating a calorie deficit |
| Regular physical activity | Boosts metabolism, builds muscle, and improves overall health |
| Healthy sleep habits | Supports weight management and overall well-being |
| Stress management techniques | Helps prevent emotional eating and supports mental health |
In addition to diet and exercise, maintaining healthy sleep habits and incorporating stress management techniques can further support weight loss and overall well-being while taking Qsymia25. By making these lifestyle changes in conjunction with Qsymia, patients can maximize their chances of achieving their weight management goals and improving their long-term health.
“Successful weight management with Qsymia requires a holistic approach that combines the medication’s effects with healthy lifestyle modifications.” – Dr. Sarah Wilkins, Obesity Specialist
Qsymia for Adolescent Obesity
Qsymia, a prescription weight loss medication, has been approved for use in pediatric patients aged 12 years and older with a body mass index (BMI) in the 95th percentile or greater, standardized for age and sex26. This medication can be an effective option for managing obesity in adolescents, but healthcare providers will carefully monitor these patients to ensure appropriate growth and development26.
Adolescent obesity is a significant public health concern, affecting 21% (1 in 5) of U.S. adolescents26. Qsymia has been evaluated in a study of 223 individuals aged 12 to less than 17 years old, with participants on Qsymia 7.5 mg/46 mg losing an average of 4.8% of their BMI, and participants on Qsymia 15 mg/92 mg losing an average of 7.1% of their BMI over 56 weeks26. In contrast, participants on placebo gained an average of 3.3% of their BMI during the same study26.
While Qsymia can be an effective weight management tool for adolescents, it may also slow the increase in height. Healthcare providers will closely monitor adolescent patients taking Qsymia to ensure their growth and development remain on track27.
| Qsymia Pricing and Availability |
|---|
| The average retail pharmacy price for a 30-day Rx of Qsymia for patients covered by commercial insurance is $75 after a $70 copay27. For patients paying cash or if not covered by commercial insurance, the average price is $13427. |
| Patients with commercial insurance coverage can receive discounts of $65-$70 off depending on the dose quantities of Qsymia purchased27. |
| For home delivery pharmacy pricing, the cost is $98, including different pack options; additional shipping and handling fees apply27. |
It is important to note that Qsymia usage is not recommended for pregnant individuals, those with thyroid problems, glaucoma, or those taking certain medications like MAOIs27. Additionally, Qsymia may cause a range of side effects, including numbness, tingling, dizziness, dry mouth, depression, mood changes, and concentration difficulties27. More serious side effects, such as changes in heart rate, visual field defects, suicidal thoughts, severe rashes, and decreases in sweating, have also been reported27.
Adolescents and their families considering Qsymia for weight management should discuss the potential benefits and risks with their healthcare providers to make an informed decision that aligns with their specific needs and circumstances26.
Patient Support and Resources for Qsymia
Navigating the journey of weight management can be challenging, but patients prescribed Qsymia have access to valuable support and resources to guide them through the process. The Q and Me® Patient Support Program, developed based on the renowned LEARN® Program, offers a comprehensive suite of educational materials, tools, and personalized guidance to help patients maximize the benefits of Qsymia28.
Patients can explore the Qsymia Medication Guide and Full Prescribing Information, accessible through their healthcare provider or the manufacturer’s website. These resources provide detailed insights into the medication’s usage, dosage, and potential side effects, empowering patients to make informed decisions about their treatment28.
- The average retail pharmacy price for a 30-day Rx of Qsymia for patients covered by commercial insurance is $75 after a $70 copay. For patients paying cash or if not covered by commercial insurance, the average price is $13428.
- Patients with commercial insurance can receive $65 off for 3.75 mg/23 mg dose quantities of 14-15 days and for all other doses with quantities of 28-30 days28.
- Patients paying cash or without commercial insurance coverage can get $70 off for 3.75 mg/23 mg dose quantities of 14-15 days and $75 off for all other doses with quantities of 28-30 days28.
- Home delivery pharmacy pricing for Qsymia is $98 and includes 6-week New Patient Packs, 6-week Titration Packs, and all 30-day prescriptions. Additional shipping and handling costs apply28.
Qsymia is indicated for use in adults with a BMI of 30 kg/m2 or greater (obese) or 27 kg/m2 or greater (overweight) with weight-related medical conditions, as well as in pediatric patients aged 12 years and older with a BMI in the 95th percentile or greater for their age and sex29.
It’s crucial for patients to report any side effects or concerns to their healthcare provider promptly, as Qsymia may carry risks such as increased heart rate, visual field defects, suicidal thoughts or actions, mood changes, metabolic acidosis, low blood sugar, and allergic reactions28.
“The Q and Me® Patient Support Program is designed to provide comprehensive resources and guidance to help patients navigate their weight management journey with Qsymia.”
By leveraging the patient support and educational resources available, individuals prescribed Qsymia can take an active role in their weight management, ultimately enhancing their chances of achieving their health and wellness goals28.
Qsymia: Long-Term Weight Management
Qsymia is designed to support individuals in their long-term weight management journey. Unlike many weight loss medications that focus solely on short-term results, Qsymia is formulated to facilitate sustainable weight loss and maintenance over an extended period1.
Studies have shown that Qsymia can be highly effective for long-term weight management. Approximately 70% of adults who took the maximum dose of Qsymia lost at least 5% of their body weight after one year, and around 50% lost at least 10% of their starting weight15. This significant weight loss was often achieved within the first 8 weeks of taking the medication15.
Healthcare providers play a crucial role in supporting patients on Qsymia. They closely monitor progress, adjust dosages as needed, and work closely with patients to ensure the long-term success of the treatment. Regular check-ups and lab tests help identify any potential side effects or health concerns, allowing for timely interventions1.
Maintaining weight loss can be challenging, but Qsymia provides a comprehensive approach to chronic weight management. By combining the medication’s appetite-suppressing and metabolic-boosting effects with a healthy lifestyle, patients can achieve and sustain their desired weight over the long term15.
It’s important to note that long-term use of Qsymia over a little more than 2 years has been deemed safe and effective in studies15. However, patients must be vigilant about potential side effects and report any new symptoms to their healthcare provider immediately.
“Qsymia has been a game-changer for me in my battle against obesity. I’ve been able to lose a significant amount of weight and keep it off for over two years now. The support from my healthcare team has been invaluable in helping me navigate the long-term management of my condition.”
Qsymia offers a comprehensive solution for individuals seeking long-term weight management. By combining the medication’s proven efficacy with personalized support and lifestyle changes, patients can achieve and maintain their weight loss goals for the long term115.
Conclusion
Qsymia, a prescription weight loss medication, offers a comprehensive approach to chronic weight management for both adults and adolescents. By combining appetite suppression and increased metabolic rate, Qsymia can help individuals achieve significant weight loss and potentially improve weight-related health conditions30. However, it is crucial for patients to understand the potential risks and side effects associated with Qsymia, including mood changes, sleep issues, dizziness, nausea, and dry mouth, among others30.
As the obesity epidemic continues to grow worldwide, with rates more than doubling in the past three decades31, Qsymia offers a prescription-based solution that can be tailored to individual patient needs based on their BMI and other factors30. Clinical trials have shown Qsymia can generate clinically significant weight loss of 6.6% of body weight, with the benefits being maintained over two years31. Nonetheless, the incremental cost-effectiveness of Qsymia compared to diet and exercise remains an area for further research31.
In conclusion, Qsymia is a valuable tool in the fight against obesity and its associated health complications, but patients must work closely with their healthcare providers to determine if it is the right treatment option for their individual needs and goals3031. By combining Qsymia with lifestyle changes, individuals can take an active role in their long-term weight management and overall health.
FAQ
What is Qsymia?
Qsymia is a prescription weight loss medication designed to help adults and adolescents aged 12 and older manage their weight. It combines two active ingredients, phentermine and topiramate, to suppress appetite and increase metabolic rate.
How does Qsymia work for weight management?
Qsymia works by combining two active ingredients, phentermine and topiramate, to target both appetite and metabolism. Phentermine acts as an appetite suppressant, reducing feelings of hunger and cravings, while topiramate helps increase metabolic rate, leading to greater calorie expenditure.
Who is eligible to take Qsymia?
Qsymia is approved for chronic weight management in adults with a body mass index (BMI) of 30 kg/m2 or greater (obese) or 27 kg/m2 or greater (overweight) with at least one weight-related medical condition. It is also approved for use in pediatric patients aged 12 and older with a BMI in the 95th percentile or greater, standardized for age and sex.
What are the potential benefits of Qsymia?
Qsymia has been shown to help individuals achieve significant weight loss when used in combination with a reduced-calorie diet and increased physical activity. Clinical studies have demonstrated that Qsymia can lead to improvements in weight-related medical conditions, such as high blood pressure, type 2 diabetes, and high cholesterol.
How is Qsymia dosed and administered?
Qsymia is typically started at a lower dose and gradually increased, a process known as titration, to help the body adjust to the medication. The recommended maintenance dosage is 7.5 mg/46 mg or 15 mg/92 mg once daily, taken with food.
What are the important safety considerations for Qsymia?
Qsymia has potential serious side effects, including suicidal thoughts or actions, eye problems, metabolic acidosis, and kidney stones. It is contraindicated in pregnant women, individuals with glaucoma, those with hyperthyroidism, and those taking certain monoamine oxidase inhibitor (MAOI) medications.
How is Qsymia used during pregnancy?
Qsymia is not recommended for use during pregnancy, as it can increase the risk of birth defects, specifically cleft lip and cleft palate. Patients who can become pregnant should have a pregnancy test before starting Qsymia and every month while taking the medication.
How is patient progress monitored during Qsymia treatment?
Patients taking Qsymia will need to undergo regular check-ups and laboratory tests to monitor for potential side effects and ensure the medication is working effectively. Healthcare providers will check the patient’s heart rate, monitor for signs of metabolic acidosis, and perform other necessary tests.
What are the most common side effects of Qsymia?
The most common side effects of Qsymia include numbness, tingling or burning sensation in the arms, feet or face, dizziness, changes in taste or loss of taste, trouble sleeping, constipation, and dry mouth.
How much does Qsymia cost, and what options are available for affordability?
The average retail pharmacy price for a 30-day supply of Qsymia is for patients covered by commercial insurance, after a copay. For patients paying cash or if Qsymia is not covered by their insurance, the average price is 4. Patients with commercial insurance coverage may be eligible for savings programs that can provide up to or off the cost of Qsymia.
How does Qsymia fit into a comprehensive weight management plan?
Qsymia is designed to be used in combination with a reduced-calorie diet and increased physical activity for effective chronic weight management. Patients taking Qsymia are encouraged to make lifestyle changes, such as adopting a balanced, calorie-controlled diet and engaging in regular exercise, to support their weight loss goals and overall health.
How is Qsymia used for adolescent obesity?
Qsymia is approved for use in pediatric patients aged 12 years and older with a body mass index (BMI) in the 95th percentile or greater, standardized for age and sex. Healthcare providers will carefully monitor adolescent patients taking Qsymia to ensure appropriate growth and development.
What resources are available to support patients taking Qsymia?
The Q and Me® Patient Support Program provides resources and support for individuals taking Qsymia, including educational materials, tools, and guidance to help patients throughout their weight management journey.
How effective is Qsymia for long-term weight management?
Qsymia is designed for chronic weight management, meaning it can be used long-term to help patients maintain their weight loss. The ultimate goal is to support patients in achieving and sustaining their desired weight over the long-term.
Source Links
- https://qsymia.com/ – Prescription Weight Loss with Qsymia® (Phentermine and Topiramate extended-release capsules) CIV
- https://qsymia.com/adult – Adult Prescription Weight Loss with Qsymia® (Phentermine and Topiramate extended-release capsules) CIV
- https://www.goodrx.com/qsymia/what-is – Qsymia (phentermine / topiramate ER): Uses, Side Effects, Dosage & Reviews
- https://qsymia.com/patient/how-qsymia-works – All-Day Hunger + Cravings Control with Qsymia® (Phentermine and Topiramate extended-release capsules) CIV
- https://www.drugs.com/medical-answers/how-qsymia-work-weight-loss-3573843/ – How Does Qsymia work for weight loss?
- https://qsymia.com/patient/resources/faqs – FAQs for Qsymia® (Phentermine and Topiramate extended-release capsules) CIV
- https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=40dd5602-53da-45ac-bb4b-15789aba40f9 – DailyMed – QSYMIA- phentermine and topiramate capsule, extended release
- https://www.drugs.com/drug-interactions/phentermine-topiramate,qsymia.html – Qsymia Interactions Checker – Drugs.com
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3814438/ – Phentermine/Topiramate Extended-Release Capsules (Qsymia) for Weight Loss
- https://lifestylemedicalcenters.com/qsymia-phentermine-topiramate/ – Qsymia (phentermine-topiramate) | Lifestyle Medical Centers
- https://www.aafp.org/pubs/afp/issues/2014/1015/p576.html – Phentermine/Topiramate (Qsymia) for Chronic Weight Management
- https://www.drugs.com/dosage/qsymia.html – Qsymia Dosage Guide – Drugs.com
- https://qsymia.com/patient/resources/taking-qsymia – Dosing Information | Qsymia® (Phentermine and Topiramate extended-release capsules) CIV
- https://hcp.qsymia.com/prescribing/ – Prescribing | Qsymia® (Phentermine and Topiramate extended-release) Capsules CIV
- https://www.goodrx.com/qsymia/how-to-take – How to Take Qsymia for Weight Loss: Dos And Don’ts – GoodRx
- https://qsymiaengage.com/faqs – Qsymia Engage: FAQs
- https://www.drugs.com/qsymia.html – Qsymia: Uses, Dosage, Reviews & Side Effects – Drugs.com
- https://www.drugs.com/pregnancy/phentermine-topiramate.html – Phentermine / topiramate (Qsymia) Use During Pregnancy
- https://qsymia.com/patient/include/media/pdf/patient-brochure.pdf?v=2306 – PDF
- https://qsymia.com/patient/resources/safety-information – Safety Information | Qsymia® (Phentermine and Topiramate extended-release capsules) CIV
- https://www.mayoclinic.org/drugs-supplements/phentermine-and-topiramate-oral-route/side-effects/drg-20075700?p=1 – Phentermine And Topiramate (Oral Route) Side Effects
- https://www.medicinenet.com/side_effects_of_qsymia_phentermine_and_topiramate/side-effects.htm – Side Effects of Qsymia (phentermine and topiramate): Interactions & Warnings
- https://qsymia.com/patient/multiple-ways-to-save – Exclusive Pricing and Home Delivery of Qsymia® (Phentermine and Topiramate extended-release capsules) CIV.
- https://www.medicalnewstoday.com/articles/drugs-qsymia-cost – Qsymia cost 2024: Coupons and more
- https://pro.aace.com/files/obesity/toolkit/qsymia_patient_info.pdf – Untitled
- https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-treatment-chronic-weight-management-pediatric-patients-aged-12-years-and-older – FDA approves treatment for chronic weight management in pediatric pati
- https://qsymia.com/caregiver – Prescription Weight Loss with Qsymia® (Phentermine and Topiramate extended-release capsules) CIV
- https://qsymia.com/patient/resources/downloads – Downloads® (Phentermine and Topiramate extended-release capsules) CIV
- https://qsymiaengage.com/ – Qsymia Engage
- https://www.rxlist.com/qsymia-drug.htm – Qsymia (Phentermine and Topiramate): Side Effects, Uses, Dosage, Interactions, Warnings
- https://link.springer.com/article/10.1007/s40273-014-0182-6 – Cost-Effectiveness Analysis of Qsymia for Weight Loss – PharmacoEconomics
Leave a Reply